BIO-TECHNE News Headlines (NASDAQ:TECH)

$200.43
+2.93 (+1.48 %)
(As of 09/22/2019 06:38 AM ET)
Today's Range
$197.03
Now: $200.43
$201.6550
50-Day Range
$184.69
MA: $194.19
$212.66
52-Week Range
$132.75
Now: $200.43
$217.15
Volume193,587 shs
Average Volume170,304 shs
Market Capitalization$7.59 billion
P/E Ratio52.74
Dividend Yield0.65%
Beta1.21

Headlines

BIO-TECHNE (NASDAQ TECH) News Headlines

Source:
DateHeadline
Bio-Techne Attains ISO 9001:2015 Certification for Fetal Bovine Serum Manufacturing FacilityBio-Techne Attains ISO 9001:2015 Certification for Fetal Bovine Serum Manufacturing Facility
finance.yahoo.com - September 18 at 6:55 AM
BIO-TECHNE Corp (NASDAQ:TECH) Short Interest Up 8.4% in AugustBIO-TECHNE Corp (NASDAQ:TECH) Short Interest Up 8.4% in August
www.americanbankingnews.com - September 14 at 7:25 PM
BIO-TECHNE Corp (NASDAQ:TECH) Given Consensus Recommendation of "Hold" by BrokeragesBIO-TECHNE Corp (NASDAQ:TECH) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - September 12 at 3:05 AM
BIO-TECHNE Corp (NASDAQ:TECH) CEO Charles R. Kummeth Purchases 200 SharesBIO-TECHNE Corp (NASDAQ:TECH) CEO Charles R. Kummeth Purchases 200 Shares
www.americanbankingnews.com - September 11 at 6:49 PM
BIO-TECHNE Corp (NASDAQ:TECH) Expected to Post Quarterly Sales of $180.37 MillionBIO-TECHNE Corp (NASDAQ:TECH) Expected to Post Quarterly Sales of $180.37 Million
www.americanbankingnews.com - September 8 at 5:48 AM
$1.08 Earnings Per Share Expected for BIO-TECHNE Corp (NASDAQ:TECH) This Quarter$1.08 Earnings Per Share Expected for BIO-TECHNE Corp (NASDAQ:TECH) This Quarter
www.americanbankingnews.com - September 6 at 10:46 AM
Bio-Techne Breaks Below 200-Day Moving Average - Notable for TECHBio-Techne Breaks Below 200-Day Moving Average - Notable for TECH
www.nasdaq.com - September 3 at 6:55 PM
Bio-Techne Corp (TECH) Files 10-K for the Fiscal Year Ended on June 30, 2019Bio-Techne Corp (TECH) Files 10-K for the Fiscal Year Ended on June 30, 2019
finance.yahoo.com - August 29 at 11:22 AM
Bio-Techne (NASDAQ:TECH) Shareholders Booked A 99% Gain In The Last Five YearsBio-Techne (NASDAQ:TECH) Shareholders Booked A 99% Gain In The Last Five Years
finance.yahoo.com - August 27 at 9:35 AM
Bio-Techne Introduces Maurice Empower® Control Kit For The Maurice™ SystemBio-Techne Introduces Maurice Empower® Control Kit For The Maurice™ System
finance.yahoo.com - August 20 at 10:28 AM
New Strong Sell Stocks for August 15thNew Strong Sell Stocks for August 15th
finance.yahoo.com - August 15 at 9:28 AM
Bio-Techne To Present At The Baird 2019 Global Healthcare ConferenceBio-Techne To Present At The Baird 2019 Global Healthcare Conference
finance.yahoo.com - August 15 at 9:28 AM
Ex-Dividend Reminder: Duke Energy, Aqua America and Bio-TechneEx-Dividend Reminder: Duke Energy, Aqua America and Bio-Techne
www.nasdaq.com - August 13 at 7:30 PM
Bio-Techne And Cygnus Technologies Announce Partnership For 3G CHO-HCP AssayBio-Techne And Cygnus Technologies Announce Partnership For 3G CHO-HCP Assay
finance.yahoo.com - August 13 at 9:22 AM
HER2(ErbB2)Antibodies Market Analysed by Business Growth, Development Factors and Future Trends by 2026HER2(ErbB2)Antibodies Market Analysed by Business Growth, Development Factors and Future Trends by 2026
www.marketwatch.com - August 9 at 7:29 PM
Edited Transcript of TECH earnings conference call or presentation 6-Aug-19 1:00pm GMTEdited Transcript of TECH earnings conference call or presentation 6-Aug-19 1:00pm GMT
finance.yahoo.com - August 7 at 12:20 AM
TECH Falls to Levels Below Book ValueTECH Falls to Levels Below Book Value
www.nasdaq.com - August 6 at 7:18 PM
Relative Strength Alert For Bio-Techne CorpRelative Strength Alert For Bio-Techne Corp
www.nasdaq.com - August 6 at 7:18 PM
Techne (TECH) Q4 Earnings and Revenues Lag EstimatesTechne (TECH) Q4 Earnings and Revenues Lag Estimates
finance.yahoo.com - August 6 at 7:18 PM
Bio-Techne Corp (TECH) Q4 2019 Earnings Call TranscriptBio-Techne Corp (TECH) Q4 2019 Earnings Call Transcript
finance.yahoo.com - August 6 at 7:18 PM
Bio-Techne EPS misses by $0.09, misses on revenueBio-Techne EPS misses by $0.09, misses on revenue
seekingalpha.com - August 6 at 8:17 AM
Bio-Techne Q4 2019 Earnings PreviewBio-Techne Q4 2019 Earnings Preview
seekingalpha.com - August 5 at 7:16 PM
Why Bio-Techne Corporations (NASDAQ:TECH) High P/E Ratio Isnt Necessarily A Bad ThingWhy Bio-Techne Corporation's (NASDAQ:TECH) High P/E Ratio Isn't Necessarily A Bad Thing
finance.yahoo.com - July 25 at 8:56 AM
Why Bio-Techne Corporation's (NASDAQ:TECH) High P/E Ratio Isn't Necessarily A Bad ThingWhy Bio-Techne Corporation's (NASDAQ:TECH) High P/E Ratio Isn't Necessarily A Bad Thing
finance.yahoo.com - July 25 at 8:56 AM
Uman Diagnostics And Bio-Techne Announce License And Supply Agreement For Neurofilament Light AssayUman Diagnostics And Bio-Techne Announce License And Supply Agreement For Neurofilament Light Assay
finance.yahoo.com - July 23 at 10:51 AM
CBM or TECH: Which Is the Better Value Stock Right Now?CBM or TECH: Which Is the Better Value Stock Right Now?
finance.yahoo.com - July 22 at 6:29 PM
Cell Separation and Characterization in Solid Tumors Market 2019| Report Growth During by 2024 - MRE AnalysisCell Separation and Characterization in Solid Tumors Market 2019| Report Growth During by 2024 - MRE Analysis
www.marketwatch.com - July 18 at 6:05 PM
Bio-Techne To Host Conference Call On August 6, 2019, To Announce Fourth Quarter 2019 Financial ResultsBio-Techne To Host Conference Call On August 6, 2019, To Announce Fourth Quarter 2019 Financial Results
finance.yahoo.com - July 18 at 9:52 AM
Bio-Techne Releases 32x8 Cartridge For The Ella PlatformBio-Techne Releases 32x8 Cartridge For The Ella Platform
finance.yahoo.com - July 17 at 9:25 AM
Bio-techne Corp (TECH) CEO Charles R. Kummeth Sold $3.6 million of SharesBio-techne Corp (TECH) CEO Charles R. Kummeth Sold $3.6 million of Shares
finance.yahoo.com - July 13 at 10:29 AM
Bio-Techne Announces Commercial Release Of RNAscope® HiPlex Assay: A Multiplex In Situ Hybridization Assay For TissuesBio-Techne Announces Commercial Release Of RNAscope® HiPlex Assay: A Multiplex In Situ Hybridization Assay For Tissues
finance.yahoo.com - July 11 at 5:33 PM
Bio-techne Corp (TECH) CEO Charles R. Kummeth Sold $7 million of SharesBio-techne Corp (TECH) CEO Charles R. Kummeth Sold $7 million of Shares
finance.yahoo.com - July 11 at 9:07 AM
Why the Earnings Surprise Streak Could Continue for Techne (TECH)Why the Earnings Surprise Streak Could Continue for Techne (TECH)
finance.yahoo.com - July 9 at 5:54 PM
Bio-Techne CEO Chuck Kummeth Wins Entrepreneur Of The Year® 2019 Award In The HeartlandBio-Techne CEO Chuck Kummeth Wins Entrepreneur Of The Year® 2019 Award In The Heartland
www.prnewswire.com - July 9 at 9:23 AM
The Daily Biotech Pulse: FDA Approves Karyopharms Blood Cancer Treatment, Grifols Immunodeficiency Drug; ESMO, ISTH Conferences In The SpotlightThe Daily Biotech Pulse: FDA Approves Karyopharm's Blood Cancer Treatment, Grifols' Immunodeficiency Drug; ESMO, ISTH Conferences In The Spotlight
feeds.benzinga.com - July 5 at 9:43 AM
At US$209, Is Bio-Techne Corporation (NASDAQ:TECH) Worth Looking At Closely?At US$209, Is Bio-Techne Corporation (NASDAQ:TECH) Worth Looking At Closely?
finance.yahoo.com - July 2 at 5:51 PM
Bio-Techne China Recognized With "Decade of Contribution Award"Bio-Techne China Recognized With "Decade of Contribution Award"
finance.yahoo.com - June 26 at 5:46 PM
Bio-Techne Appoints Rupert Vessey to Board of DirectorsBio-Techne Appoints Rupert Vessey to Board of Directors
finance.yahoo.com - June 25 at 6:30 PM
Trastuzumab Industry 2019-2026 | Global Market Trends, Applications, Size, Types, Key Manufacturers and Forecast ResearchTrastuzumab Industry 2019-2026 | Global Market Trends, Applications, Size, Types, Key Manufacturers and Forecast Research
www.marketwatch.com - June 24 at 5:01 PM
Here’s What Hedge Funds Think About Bio-Techne Corporation (TECH)Here’s What Hedge Funds Think About Bio-Techne Corporation (TECH)
finance.yahoo.com - June 19 at 7:33 AM
Bio-Techne nabs accelerated review in U.S. for ExoDx EPI testBio-Techne nabs accelerated review in U.S. for ExoDx EPI test
seekingalpha.com - June 17 at 9:56 AM
FDA Grants Breakthrough Device Designation To Bio-Technes ExoDx™ Prostate IntelliScore™ (EPI) TestFDA Grants Breakthrough Device Designation To Bio-Techne's ExoDx™ Prostate IntelliScore™ (EPI) Test
finance.yahoo.com - June 17 at 9:56 AM
FDA Grants Breakthrough Device Designation To Bio-Technes ExoDx(TM) Prostate IntelliScore(TM) (EPI) TestFDA Grants Breakthrough Device Designation To Bio-Techne's ExoDx(TM) Prostate IntelliScore(TM) (EPI) Test
www.prnewswire.com - June 17 at 9:54 AM
Bio-Techne gets NY nod for prostate testBio-Techne gets NY nod for prostate test
seekingalpha.com - June 13 at 6:36 PM
Bio-Techne Receives Approval To Offer The ExoDx™ Prostate Intelliscore™ (EPI) Test In New York StateBio-Techne Receives Approval To Offer The ExoDx™ Prostate Intelliscore™ (EPI) Test In New York State
finance.yahoo.com - June 13 at 6:36 PM
If You Like EPS Growth Then Check Out Bio-Techne (NASDAQ:TECH) Before Its Too LateIf You Like EPS Growth Then Check Out Bio-Techne (NASDAQ:TECH) Before It's Too Late
finance.yahoo.com - June 6 at 9:18 AM
If You Like EPS Growth Then Check Out Bio-Techne (NASDAQ:TECH) Before It's Too LateIf You Like EPS Growth Then Check Out Bio-Techne (NASDAQ:TECH) Before It's Too Late
finance.yahoo.com - June 6 at 9:18 AM
Bio-Techne acquires Minneapolis gene-editing firm formed at U of MBio-Techne acquires Minneapolis gene-editing firm formed at U of M
www.bizjournals.com - June 5 at 6:16 PM
Bio-Techne To Acquire B-MoGen Biotechnologies Inc.Bio-Techne To Acquire B-MoGen Biotechnologies Inc.
finance.yahoo.com - June 4 at 6:06 PM
Bio-Techne To Present At The Goldman Sachs 40th Annual Global Healthcare ConferenceBio-Techne To Present At The Goldman Sachs 40th Annual Global Healthcare Conference
finance.yahoo.com - June 3 at 6:05 PM
This page was last updated on 9/22/2019 by MarketBeat.com Staff

Featured Article: 12b-1 Fees

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel